Use of Polygenic Scores to Select Embryos

Authors:

Abstract
Turley et al. (July 1 issue)1 state that MyOme “appears” to currently provide embryo selection using polygenic scores (ESPS) for nondisease traits. Although it may have appeared to be so, it is in fact not the case. Their statement was based on archived draft materials. We are conducting free-to-participant studies to assess the utility and tractability of ESPS. Although some participants have sought information on traits such as educational attainment, we determined that these issues distract from our health-focused conversation and mission. We generally agree with the recommendations of Turley et al. regarding messaging, augmented by an additional explanation of limitations. Nonetheless, feedback from our study has been positive; couples appreciate and feel empowered by the additional information, especially when the polygenic score modulates an increased family-history risk.